Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two Fractions — Stella

Home/Prostate Cancer (Adenocarcinoma)/Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two Fractions

View on ClinicalTrials.gov

Recruiting

Back to Prostate Cancer (Adenocarcinoma) trials

Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two Fractions

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Netherlands

The Netherlands Cancer Institute, Amsterdam

Key details

Sponsor

The Netherlands Cancer Institute

Collaborators

MRL Consortium, Elekta Limited

Enrollment target

~54 participants

Started

November 2025

Primary completion

February 2027

Age range

18 Years and older

Sex

Male only

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.